<?xml encoding="utf-8" ?> Biomarin Pharmaceutical BMRN reported third-quarter financial results on Monday. The transcript ...

Let me answer the question this way. We believe that the size of the study that we've put in place and the models that we're using, again, we'll be looking at AGV for the individual cohorts, but we ...

Clinical, manufacturing, safety, and commercial teams all lean on shared data. They need to agree on who publishes each data product, who can use it, and what evidence goes with it.

Agrifreeze Korea market entry highlights why biotech partnerships need access to controlled materials, trusted collaborators, and practical first trials.

Should a biotech hand its molecule to a single integrated partner, or build a network of specialists around it? Manufacturers and clinical providers are answering in both directions at once: some are ...

Technology transfer creates plenty of documentation. Process descriptions, risk assessments, batch records, specifications, ...

Ghana has taken a significant step toward overhauling its healthcare and industrial landscape with the launch of the Ghana Pharmaceutical Manufacturing Policy (GPMP).

Thank you for joining us, and welcome to the BioMarin Third Quarter 26 Conference Call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, ...

Need a bit of help with NYT Strands today? No shame in that, and you've come to the right place. Below, we've compiled some useful hints for Strands #975 as well as the answers, should it come to that ...

Other restricted stock units vested August 15, 2026, with additional vesting scheduled for August 15, 2027 and August 15, 2028.